Bank of New York Mellon »

Tenax Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Tenax Therapeutics (TENX) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Tenax Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenax Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenax Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.7M 325k 14.55

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Micron Technology (MU)
Meta Platforms Inc-class A Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Tenax Therapeutics

FMR
T. Rowe Price Associates
Vivo Capital
Henderson Group
BlackRock
Perceptive Advisors
Ikarian Capital
Vanguard Capital Management
Citadel Advisors
Millennium Management
Candriam Luxembourg S.C.A.
Caption Management
Rtw Investments
Stonepine Capital Management
Geode Capital Management

View all funds holding Tenax Therapeutics